Antithrombotic treatment, particularly aspirin, is prescribed in the prevention of cardiovascular events; however recent studies have shown little or no benefit of aspirin use in primary prevention.

Findings From Analysis of 30827 Patients at Risk for HF Enrolled in Six Observational Studies

Aspirin Use is Associated with Incident HF, Independent of Other Risk Factors. It Should be Prescribed with Caution in Patients at Risk of HF or Having HF.

HF: Heart failure